HNN3.0

Project cooperationUpdated on 26 January 2026

Exploring partnerships || discovery, POC, commercialization, valorization

Executive Director HDI Group, EIC innovation expert at Human Data Insight Group

Bucharest, Romania

About

About

Human Data Insight Group (HDI) is a health and life sciences innovation and impact organisation supporting Horizon Europe Cluster Health projects with early discovery, applied innovation, and real-world uptake capabilities. HDI works at the intersection of health systems, behavioural insight, and early-stage technical validation, helping consortia ensure that research outcomes are grounded in real needs and translated into trusted, usable solutions.

HDI combines experience from EU-funded programmes, health systems, academia, and industry to bridge gaps between research, clinical practice, and innovation adoption, with a particular focus on mental health, workforce challenges, and system integration.

Project / Approach Overview

HDI’s approach is centred on problem-first innovation, ensuring that Horizon Health projects address clearly defined needs and generate outcomes that are relevant, credible, and scalable.

HDI supports projects across three tightly connected layers:

1. Discovery & problem definition

  • Identification and sizing of unmet needs (e.g. staff shortages, care fragmentation, mental health access gaps)

  • Quantitative and qualitative analyses (surveys, questionnaires, mixed methods)

  • Behavioural insight to understand how challenges manifest in daily clinical and system workflows

2. Co-creation & early technical validation (POC level)

  • Design and facilitation of hackathons, living labs, and behavioural labs with students, clinicians, and experts

  • Early proof-of-concept (TRL 2–4) development for:

    • interoperability concepts across fragmented tools and services

    • workflow and coordination solutions addressing clinician workload and staff shortages

    • clinician-facing mental health interventions supporting continuity of care and ethical practice

  • Feasibility testing and user validation in real-world contexts

  1. Commercialization

    HDI Group provides world-class EU project management and commercialization expertise, having successfully secured and managed health projects. Our extensive network spans 200+ stakeholders including health tech accelerators, venture capital firms, and strategic corporate partners across Europe.

•         Project management: 100% on-time delivery rate, experienced in multi-regional consortium coordination, established relationships with UNITE regional representatives

•         Market access: Partnerships with 5 EU health accelerators, connections to 15+ hospital networks, established pathways in 7 EU markets

4. Valorisation, uptake & sustainability

  • Communication, dissemination, and outreach aligned with Horizon requirements

  • Stakeholder engagement with universities, healthcare providers, industry, insurers, and policymakers

  • Support for transforming validated concepts into initiatives, services, or entrepreneurial pathways

  • Impact measurement and sustainability planning beyond the project lifecycle

HDI does not position itself as a full-scale technology developer or clinical trial operator, but as an early innovation and system-integration partner, preparing concepts for downstream development by specialised partners.Role in the Consortium

HDI seeks to participate as a beneficiary and applied innovation partner, contributing to both strategic and hands-on activities.

HDI may also act as work-package leader or coordinator for selected Coordination and Support Actions (CSAs) or system-focused RIAs.

Type of Partners Sought

HDI is looking to collaborate within Horizon Europe Cluster Health consortia with:

  • Universities and research organisations

  • Hospitals and mental health service providers

  • Technology partners for scaling and advanced development

  • Public authorities, insurers, and policy stakeholders

  • Coordinators seeking partners strong in discovery, engagement, and impact

HDI values consortia that recognise early validation, co-creation, and uptake as critical success factors alongside scientific excellence.

Collaboration Interest

HDI is open to joining consortia as:

  • An early innovation and discovery partner

  • A POC-level technical contributor focused on interoperability and clinician support

  • A work-package leader for co-creation, engagement, valorisation, and impact

  • A core partner bridging research outputs with system and societal needs

Topic

  • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Type

  • Partner seeks Consortium/Coordinator

Organisation

Human Data Insight Group

Consultancy

Bucharest, Romania

Similar opportunities